- XXV
iPath® Inverse S&P 500 VIX Short-Term Futures™ ETN - IVOP
iPath® Inverse S&P 500 VIX Short-Term Futures™ ETN (II) - VZZB
iPath® Long Enhanced S&P 500 VIX Mid-Term Futures™ ETN (II) - XVZ
iPath® S&P 500 Dynamic VIX ETN - VXZ
iPath® S&P 500 VIX Mid-Term Futures™ ETN - VXX
iPath® S&P 500 VIX Short-Term Futures™ ETN
iPath Exchange Traded Notes (ETNs) are innovative investment products from Barclays Bank PLC. They provide investors with access to a wide range of equity exposures and strategies with single-trade access to leveraged equities, strategies, international equity and equity volatility.
iPath ETNs feature:
- Cost efficiency
- Daily exchange liquidity
- Index tracking
Go long. Go short. Go leveraged, international, or strategic. iPath gives you the tools to express your views on equities.
Leveraged Equity (click product name to see current participation rate)
Equity Strategy
iPath ETN |
Ticker |
Yearly Fee¹ |
| iPath® CBOE S&P 500 BuyWrite IndexSM ETN | BWV | 0.75% |
International Equity
iPath ETN |
Ticker |
Yearly Fee¹ |
| iPath® MSCI India IndexSM ETN | INP | 0.89% |
Equity Volatility
iPath ETN |
Ticker |
Yearly Fee¹ |
| iPath® Inverse S&P 500 VIX Short-Term Futures™ ETN | XXV | 0.89% |
| iPath® Inverse S&P 500 VIX Short-Term Futures™ ETN (II) | IVOP | 0.89% |
| iPath® Long Enhanced S&P 500 VIX Mid-Term Futures™ ETN (II) | VZZB | 0.89% |
| iPath® S&P 500 Dynamic VIX ETN | XVZ | 0.95% |
| iPath® S&P 500 VIX Mid-Term Futures™ ETN | VXZ | 0.89% |
| iPath® S&P 500 VIX Short-Term Futures™ ETN | VXX | 0.89% |
¹The investor fee is calculated cumulatively based on the Yearly Fee and the performance of the underlying index or currency exchange rate and increases each day based on the level of the index or currency exchange rate on that day. Because the investor fee reduces the amount of your return at maturity or upon redemption, if the value of the underlying decreases or does not increase significantly, you may receive less than the principal amount of your investment at maturity or upon redemption. For a more complete description of how the investor fee is calculated and any other applicable costs, including the daily financing charge or borrow rate applicable to the leveraged equity ETNs, please see the applicable product page and Pricing Supplement at www.iPathETN.com.
With short sales, an investor faces the potential for unlimited losses as the security's price rises.
An investment in iPath ETNs involves risks, including possible loss of principal.
Barclays Bank PLC has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus and other documents Barclays Bank PLC has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting www.iPathETN.com or EDGAR on the SEC website at www.sec.gov. Alternatively, Barclays Bank PLC will arrange for Barclays Capital Inc. to send you the prospectus if you request it by calling toll-free 1-877-764-7284, or you may request a copy from any other dealer participating in the offering.
BlackRock Investments, LLC, assists in the promotion of the iPath ETNs.
Selected Risk Considerations
An investment in the iPath ETNs (the "Securities") involves risks. Selected risks are summarized here, but we urge you to read the more detailed explanation of risks described under "Risk Factors" in the applicable prospectus supplement and pricing supplement. Capitalized terms used below but not defined herein shall have the meanings attributed to them in the applicable prospectus supplement and pricing supplement.
Credit of Barclays PLC: The Securities are unsecured obligations of Barclays Bank PLC and are not secured debt. The Securities are riskier than ordinary unsecured debt securities and have no principal protection. Risks of investing in the Securities include limited portfolio diversification trade price fluctuations, uncertain principal repayment and liquidity. Investing in the Securities is not equivalent to investing directly in an index or in any particular index components. The investor fee will reduce the amount of your return at maturity or on redemption and as a result you may receive less than the principal amount of your investment at maturity or upon redemption of your Securities if the level of the relevant index has increased or decreased (as may be applicable to the particular series of Securities). An investment in the Securities may not be suitable for all investors.
Restrictions on the Minimum Number of Securities and Date Restrictions for Redemptions: The Securities may be sold throughout the day on the exchange through any brokerage account. There are restrictions on the minimum number of Securities you may redeem directly with the issuer as specified in the applicable pricing supplement. You may only redeem your Securities on an optional redemption date if we receive notice of the redemption from you by certain dates and times as set forth in the pricing supplement. Commissions may apply and there are tax consequences in the event of sale, redemption or maturity of Securities. Sales in the secondary market may result in significant losses.
Leverage Risk: For an investment in Securities ("iPath Long ETNs") linked to a leveraged participation in the performance of the S&P 500® Total Return Index, the Russell 1000® Total Return Index, the Russell 2000® Total Return Index, the MSCI EAFE® Net Total Return Index, the MSCI Emerging Markets Net Total Return Index, or the S&P 500® VIX Mid-Term Futures Total Return Index, any decrease in the level of the underlying index will result in a significantly greater decrease in the repayment amount and you may receive less than your original investment in the Securities at maturity or upon redemption. For an investment in Securities ("iPath Short ETNs") linked to a leveraged participation in the inverse performance of the S&P 500® Total Return Index, the Russell 1000® Total Return Index, the Russell 2000® Total Return Index, the MSCI EAFE® Net Total Return Index, or the MSCI Emerging Markets Net Total Return Index, any increase in the level of the underlying Index will result in a significantly greater decrease in the repayment amount and you may receive less than your original investment in the Securities at maturity or upon redemption. Leverage increases the sensitivity of the Securities to changes in the value of the underlying index. The ratio between the value of the Securities and the notional exposure of each Security to the underlying index will fluctuate during the term of the Securities.
Particular Risks Associated with the VIX Index: An investment in Securities linked to the performance of the S&P 500 VIX Short-Term Futures IndexTR or the S&P 500 VIX Mid-Term Futures Index TR is subject to particular risks associated with fluctuations in the performance of the relevant index. Because the performance of each of these indices is linked to the CBOE Volatility Index (the "VIX Index"), the performance of each index will depend on many factors including the level of the S&P 500® Index, the prices of options on the S&P 500® Index, and, consequently, the level of the VIX Index. Additional factors that may contribute to fluctuations in the level of the relevant index include prevailing market prices and forward volatility levels of the U.S. stock markets and the equity securities included in the S&P 500® index, the prevailing market prices of options on the VIX Index, relevant futures contracts on the VIX Index, or any other financial instruments related to the S&P 500® Index and the VIX Index, interest rates, supply and demand in the listed and over-the-counter equity derivative markets as well as hedging activities in the equity-linked structured product markets.
Covered Call Strategy Risk: Trading in stocks and options that comprise the covered S&P 500® Index portfolio is speculative and returns can be extremely volatile. Market prices of index components of the covered S&P 500® Index portfolio may fluctuate rapidly based on numerous factors, which may affect the value of the CBOE S&P 500 BuyWrite Index (the "BuyWrite Index") and the value of your Securities in varying ways, and different factors may cause prices of the components of the covered S&P 500® Index portfolio, and the volatilities of their prices, to move in inconsistent directions at inconsistent rates. A covered call strategy also limits participation in the appreciation of the underlying asset, in this case, the S&P 500® Index. Consequently, the BuyWrite Index will not participate fully in the appreciation of the S&P 500® Index as would an investment linked directly to the S&P 500® Index or a direct investment in the stocks underlying the S&P 500® Index. While the strike price of the call options on the S&P 500® Index will operate to limit the BuyWrite Index's participation in any increase in the value of the S&P 500® Index, the BuyWrite Index's exposure to any decline in the value of the S&P 500® Index will not be limited.
Emerging Market Risk: The market value of the Securities linked to an index with exposure to emerging markets may be influenced by many unpredictable factors and may fluctuate between the date you purchase them and the maturity date or redemption date. Investments in an emerging market carry the risk of capital loss from unfavorable fluctuation in currency values, differences in generally accepted accounting principles, lower trading volumes, and economic or political instability. Such Securities may be subject to more volatility than investments outside of emerging markets. In addition, Securities representing a concentrated investment in a single country may be more volatile than other investments.
You may lose some or all of your principal: The Securities are exposed to any change in the level of the Index caused by any daily decrease or increase (as may be applicable to a series of Securities) in the level of the applicable index. Additionally, if the level of the applicable index is insufficient to offset the negative effect of the investor fee and any other applicable costs, including the daily financing charge or borrow rate applicable to the iPath Short ETNs and iPath Long ETNs, respectively, you will lose some or all of your investment at maturity or upon redemption.
A trading market for the Securities may not develop: Although the Securities are listed on NYSE Arca, a trading market for the Securities may not develop. Certain affiliates of Barclays Bank PLC may engage in limited purchase and resale transactions in the Securities, although they are not required to and may stop at any time. We are not required to maintain any listing of the Securities on NYSE Arca or any other exchange. Therefore, the liquidity of the Securities may be limited.
No interest payments from the Securities: You will not receive any interest payments on the Securities.
Uncertain tax treatment: Significant aspects of the tax treatment of the Securities are uncertain. You should consult your own tax advisor about your own tax situation.
"Standard & Poor's®," "S&P®," "S&P 500®," "Standard & Poor's 500® ," "S&P 500 VIX Short-Term Futures"and "S&P 500 VIX Mid-Term Futures" are trademarks of Standard & Poor's Financial Services LLC ("S&P") and have been licensed for use by Barclays Bank PLC. "VIX", "BuyWrite" and "CBOE" are trademarks of the Chicago Board Options Exchange, Incorporated ("CBOE") and have been licensed for use by S&P or Barclays Bank PLC. The Securities are not sponsored, endorsed, sold or promoted by S&P or the CBOE. S&P and CBOE make no representation, condition or warranty, express or implied, to the owners of the Securities or any member of the public regarding the advisability of investing in securities generally or in the Securities or in the ability of either index to track market performance.
"Russell 1000® Index" and "Russell 2000® Index" are trademarks of Russell Investment Group and have been licensed for use by Barclays Bank PLC. The Securities are not sponsored, endorsed, sold, or promoted by Russell Investment Group and Russell Investment Group makes no representation regarding the advisability of investing in the Securities.
The MSCI indexes are the exclusive property of MSCI, Inc. ("MSCI"). MSCI and the MSCI index names are servicemark(s) of MSCI or its affiliates and have been licensed for use for certain purposes by Barclays Bank PLC. The financial securities referred to herein are not sponsored, endorsed or promoted by MSCI, and MSCI bears no liability with respect to any such financial securities. The relevant pricing supplement contains a more detailed description of the limited relationship MSCI has with Barclays Bank PLC and any related financial securities. No purchaser, seller or holder of this product, or any other person or entity, should use or refer to any MSCI trade name, trademark or servicemark to sponsor, endorse, market or promote this product without first contacting MSCI to determine whether MSCI's permission is required. Under no circumstances may any person or entity claim any affiliation with MSCI without the prior written permission of MSCI.